Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coatomer subunit gamma-2 (COPG2) is a structural component of the coatomer protein complex (COPI), which is essential for vesicle formation involved in the retrograde transport of proteins from the Golgi apparatus back to the endoplasmic reticulum and between Golgi compartments. COPG2, as part of the nonclathrin-coated vesicles, mediates key processes in intracellular trafficking, maintenance of Golgi structure, and sorting of cargo proteins within cells. It interacts with scaffolding and regulatory proteins to help assemble coatomer complexes, influencing Golgi architecture and potentially contributing to specialized cellular functions. Alterations in COPG2 expression or function have been implicated in various cancers and neurodevelopmental disorders, highlighting its potential importance in human pathophysiology, though it is not a direct drug target at present.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coatomer subunit gamma-2 (COPG2).